James Collins

This paper develops a Cas12a-based toolkit for efficient genomic editing and CRISPRi in Group B Streptococcus, enabling targeted gene modifications and inducible gene silencing with minimal off-target effects.

The study shows that mice with the synthetic microbiota OMM19.1 are susceptible to C. difficile infection without antibiotics, with increased infection severity at higher doses.